Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

EPA:UBI - Euronext Paris - Matif - FR0000054470 - Common Stock - Currency: EUR

11.195  +0.15 (+1.36%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to UBI. UBI was compared to 44 industry peers in the Entertainment industry. Both the profitability and the financial health of UBI get a neutral evaluation. Nothing too spectacular is happening here. UBI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year UBI was profitable.
In the past year UBI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: UBI reported negative net income in multiple years.
UBI had a positive operating cash flow in each of the past 5 years.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M

1.2 Ratios

The Return On Assets of UBI (-1.18%) is worse than 62.50% of its industry peers.
UBI has a Return On Equity (-3.22%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 0.81%, UBI is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROIC 0.81%
ROA(3y)-1.97%
ROA(5y)-1.46%
ROE(3y)-6.88%
ROE(5y)-4.79%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

UBI's Profit Margin has improved in the last couple of years.
UBI has a Operating Margin (2.46%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of UBI has grown nicely.
UBI has a better Gross Margin (90.35%) than 77.50% of its industry peers.
In the last couple of years the Gross Margin of UBI has grown nicely.
Industry RankSector Rank
OM 2.46%
PM (TTM) N/A
GM 90.35%
OM growth 3Y-8.08%
OM growth 5Y4.36%
PM growth 3Y13.94%
PM growth 5Y4.83%
GM growth 3Y2.2%
GM growth 5Y2.09%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

UBI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for UBI has been increased compared to 1 year ago.
The number of shares outstanding for UBI has been increased compared to 5 years ago.
Compared to 1 year ago, UBI has an improved debt to assets ratio.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

UBI has an Altman-Z score of 1.33. This is a bad value and indicates that UBI is not financially healthy and even has some risk of bankruptcy.
UBI has a better Altman-Z score (1.33) than 62.50% of its industry peers.
The Debt to FCF ratio of UBI is 4.55, which is a neutral value as it means it would take UBI, 4.55 years of fcf income to pay off all of its debts.
UBI has a better Debt to FCF ratio (4.55) than 67.50% of its industry peers.
A Debt/Equity ratio of 1.32 is on the high side and indicates that UBI has dependencies on debt financing.
The Debt to Equity ratio of UBI (1.32) is worse than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Altman-Z 1.33
ROIC/WACC0.17
WACC4.77%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

UBI has a Current Ratio of 2.32. This indicates that UBI is financially healthy and has no problem in meeting its short term obligations.
UBI has a Current ratio of 2.32. This is amongst the best in the industry. UBI outperforms 90.00% of its industry peers.
A Quick Ratio of 2.29 indicates that UBI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.29, UBI belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.29
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

4

3. Growth

3.1 Past

UBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.93%, which is quite impressive.
Measured over the past years, UBI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.43% on average per year.
Looking at the last year, UBI shows a quite strong growth in Revenue. The Revenue has grown by 11.34% in the last year.
Measured over the past years, UBI shows a small growth in Revenue. The Revenue has been growing by 4.51% on average per year.
EPS 1Y (TTM)105.93%
EPS 3Y-10.3%
EPS 5Y-8.43%
EPS Q2Q%-16500%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y1.14%
Revenue growth 5Y4.51%
Sales Q2Q%-21.9%

3.2 Future

Based on estimates for the next years, UBI will show a small growth in Earnings Per Share. The EPS will grow by 0.17% on average per year.
Based on estimates for the next years, UBI will show a small growth in Revenue. The Revenue will grow by 3.25% on average per year.
EPS Next Y-127.66%
EPS Next 2Y-31.52%
EPS Next 3Y-13.62%
EPS Next 5Y0.17%
Revenue Next Year-12.6%
Revenue Next 2Y-1.49%
Revenue Next 3Y0.37%
Revenue Next 5Y3.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 79.96, which means the current valuation is very expensive for UBI.
The rest of the industry has a similar Price/Earnings ratio as UBI.
The average S&P500 Price/Earnings ratio is at 28.47. UBI is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 13.34, which indicates a correct valuation of UBI.
UBI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. UBI is cheaper than 72.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 92.74. UBI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 79.96
Fwd PE 13.34
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

77.50% of the companies in the same industry are more expensive than UBI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, UBI is valued cheaper than 92.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.85
EV/EBITDA 3.07
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as UBI's earnings are expected to decrease with -13.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-31.52%
EPS Next 3Y-13.62%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for UBI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UBISOFT ENTERTAINMENT

EPA:UBI (2/5/2025, 10:30:25 AM)

11.195

+0.15 (+1.36%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners43.6%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.46B
Analysts66.67
Price Target16.2 (44.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.89%
PT rev (3m)-11.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-695.67%
EPS NY rev (3m)-695.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.55%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE 79.96
Fwd PE 13.34
P/S 0.69
P/FCF 2.85
P/OCF 2.33
P/B 0.86
P/tB N/A
EV/EBITDA 3.07
EPS(TTM)0.14
EY1.25%
EPS(NY)0.84
Fwd EY7.5%
FCF(TTM)3.93
FCFY35.11%
OCF(TTM)4.8
OCFY42.86%
SpS16.34
BVpS12.98
TBVpS-4.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROCE 1.34%
ROIC 0.81%
ROICexc 1.06%
ROICexgc 3.87%
OM 2.46%
PM (TTM) N/A
GM 90.35%
FCFM 24.05%
ROA(3y)-1.97%
ROA(5y)-1.46%
ROE(3y)-6.88%
ROE(5y)-4.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-33.29%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.78%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.08%
OM growth 5Y4.36%
PM growth 3Y13.94%
PM growth 5Y4.83%
GM growth 3Y2.2%
GM growth 5Y2.09%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Debt/EBITDA 2.5
Cap/Depr 13.39%
Cap/Sales 5.31%
Interest Coverage 250
Cash Conversion 69.7%
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 2.29
Altman-Z 1.33
F-Score6
WACC4.77%
ROIC/WACC0.17
Cap/Depr(3y)11.34%
Cap/Depr(5y)13.13%
Cap/Sales(3y)4.42%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.93%
EPS 3Y-10.3%
EPS 5Y-8.43%
EPS Q2Q%-16500%
EPS Next Y-127.66%
EPS Next 2Y-31.52%
EPS Next 3Y-13.62%
EPS Next 5Y0.17%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y1.14%
Revenue growth 5Y4.51%
Sales Q2Q%-21.9%
Revenue Next Year-12.6%
Revenue Next 2Y-1.49%
Revenue Next 3Y0.37%
Revenue Next 5Y3.25%
EBIT growth 1Y116.85%
EBIT growth 3Y-7.03%
EBIT growth 5Y9.06%
EBIT Next Year117.63%
EBIT Next 3Y42.52%
EBIT Next 5Y21.94%
FCF growth 1Y-45.29%
FCF growth 3Y-21.2%
FCF growth 5Y-14.04%
OCF growth 1Y-38.92%
OCF growth 3Y-17.51%
OCF growth 5Y-11.18%